GeoVax Labs, Inc. Stock Compensation Disclosure

6.         Stock-Based Compensation

 

Stock-based compensation expense related to stock options is recognized on a straight-line basis over the requisite service period for the award and is allocated to research and development expense or general and administrative expense based upon the classification of the individual to whom the award is granted. We also have issued shares of restricted common stock to consultants and recognize the related expense over the terms of the related agreements.

 

We use the Black-Scholes model for determining the grant date fair value of our stock option grants. This model utilizes certain information, such as the interest rate on a risk-free security with a term generally equivalent to the expected life of the option being valued and requires certain other assumptions, such as the expected amount of time an option will be outstanding until it is exercised or expired, to calculate the fair value of stock options granted. The significant assumptions we used in our fair value calculations for stock options were as follows:

 

		2025				2024
Weighted average risk-free interest rates			4.5	%			3.8	%
Expected dividend yield			0.0	%			0.0	%
Expected life of option (in years)			7.0				7.0
Expected volatility			179.3	%			204.2	%

 

 

The weighted-average grant date fair values of stock options granted during 2025 and 2024 were $61.05 and $55.39, respectively. As of December 31, 2025, there is $1,371,524 of unrecognized compensation expense that will be recognized over a weighted-average period of 2.0 years.

 

The following table summarizes our total stock-based compensation expense for employees, directors and consultants for the years ended December 31, 2025 and 2024:

 

		2025				2024
Stock options:
Research and development		$	513,867			$	222,202
General and administrative			597,120				252,275
Total stock option expense			1,110,987				474,477
Stock awards:
General and administrative			4,167				54,167
Total stock-based compensation expense		$	1,115,154			$	528,644